• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染中固有和适应性免疫反应的机制理解。

Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.

机构信息

Department of Molecular & Biomedical Sciences University of Maine, Orono, ME, USA; Tufts University School of Medicine, Boston, MA, USA; IT Bio, LLC, Nest.Bio Labs, Cambridge, MA, USA.

出版信息

Mol Immunol. 2021 Jul;135:268-275. doi: 10.1016/j.molimm.2021.04.021. Epub 2021 Apr 30.

DOI:10.1016/j.molimm.2021.04.021
PMID:33940513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8084627/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have triggered global pandemic that continue to impact adversely human health. New understanding has emerged about the innate and adaptive immune responses elicited in SARS-CoV-2 infection. The understanding of innate immune responses generated in hosts early in SARS-CoV-2 infection is vital for treatment efforts. Antiviral cytokines are released by innate immune cells in response to viral infections that play a pivotal role in limiting viral replication, pathology and generating optimal adaptive immune responses alongside the long-term memory responses against reinfections. One aspect of innate immune response generated against SARS-CoV-2 in vivo and which has received much attention has been high proinflammatory cytokine release in COVID-19 patients. Another vital discovery has been that the antiviral cytokine type I Interferon (IFN) family IFN-α mediates upregulation of angiotensin converting enzyme 2 (ACE2) membrane protein in airway epithelial cells. ACE2 is a receptor that SARS-CoV-2 binds to infect host cells. New understanding has emerged about the mechanism of SARS-CoV-2 induced exaggerated proinflammatory cytokine release as well as transcriptional regulation of ACE2. This review discusses various mechanisms underlying SARS-CoV-2 induced exaggerated proinflammatory cytokine response as well as transcriptional regulation of ACE2 receptor. We further elaborate on adaptive and memory responses generated against SARS-CoV-2.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染引发了全球大流行,持续对人类健康产生不利影响。人们对 SARS-CoV-2 感染引起的固有和适应性免疫反应有了新的认识。了解宿主在 SARS-CoV-2 感染早期产生的固有免疫反应对于治疗工作至关重要。抗病毒细胞因子是固有免疫细胞对病毒感染的反应释放的,在限制病毒复制、病理学和产生最佳适应性免疫反应以及针对再感染的长期记忆反应方面发挥着关键作用。固有免疫反应的一个方面是针对 SARS-CoV-2 在体内产生的,并且受到了广泛关注,即 COVID-19 患者中促炎细胞因子的大量释放。另一个重要发现是,抗病毒细胞因子 I 型干扰素(IFN)家族 IFN-α介导气道上皮细胞中血管紧张素转换酶 2(ACE2)膜蛋白的上调。ACE2 是 SARS-CoV-2 结合感染宿主细胞的受体。人们对 SARS-CoV-2 诱导的促炎细胞因子过度释放的机制以及 ACE2 受体的转录调控有了新的认识。本综述讨论了 SARS-CoV-2 诱导的促炎细胞因子反应过度以及 ACE2 受体转录调控的各种机制。我们进一步阐述了针对 SARS-CoV-2 产生的适应性和记忆反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/2fd608a91f8b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/ebfce9758693/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/5633231b0ac3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/2fd608a91f8b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/ebfce9758693/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/5633231b0ac3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/8084627/2fd608a91f8b/gr2_lrg.jpg

相似文献

1
Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.SARS-CoV-2 感染中固有和适应性免疫反应的机制理解。
Mol Immunol. 2021 Jul;135:268-275. doi: 10.1016/j.molimm.2021.04.021. Epub 2021 Apr 30.
2
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.SARS-CoV-2 感染的免疫学方面及维生素-D 的可能有益作用。
Int J Mol Sci. 2021 May 16;22(10):5251. doi: 10.3390/ijms22105251.
3
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.细胞因子风暴和I型干扰素反应在新冠病毒疾病发病机制中的关键决定因素
Clin Microbiol Rev. 2021 May 12;34(3). doi: 10.1128/CMR.00299-20. Print 2021 Jun 16.
4
Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.血管紧张素转换酶 2 通过拮抗 I 型干扰素诱导及其下游信号通路增强 SARS-CoV-2 感染。
mSphere. 2022 Aug 31;7(4):e0021122. doi: 10.1128/msphere.00211-22. Epub 2022 Jul 12.
5
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.SARS-CoV-2 分离株在人免疫细胞中的复制能力受损,但在肺上皮细胞中的复制能力和诱导先天免疫能力存在差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0077421. doi: 10.1128/Spectrum.00774-21. Epub 2021 Aug 11.
6
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
7
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
8
SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.SARS-CoV-2 与人类宿主的多方面相互作用。第二部分:先天免疫反应、免疫病理学和表观遗传学。
IUBMB Life. 2020 Nov;72(11):2331-2354. doi: 10.1002/iub.2379. Epub 2020 Sep 16.
9
ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review.ACE2 和先天免疫在调控 SARS-CoV-2 诱导的急性肺损伤中的作用:综述。
Int J Mol Sci. 2021 Oct 25;22(21):11483. doi: 10.3390/ijms222111483.
10
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.新型冠状病毒特异性免疫应答与 COVID-19 发病机制。
Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716.

引用本文的文献

1
Targeting viral suppressor of RNAi confers anti-coronaviral activity.靶向RNA干扰的病毒抑制因子可赋予抗冠状病毒活性。
Mol Ther. 2025 Jan 8;33(1):201-214. doi: 10.1016/j.ymthe.2024.12.009. Epub 2024 Dec 10.
2
Type I interferon pathway genetic variants in severe COVID-19.严重 COVID-19 中 I 型干扰素通路遗传变异。
Virus Res. 2024 Apr;342:199339. doi: 10.1016/j.virusres.2024.199339. Epub 2024 Feb 22.
3
Transcriptomics secondary analysis of severe human infection with SARS-CoV-2 identifies gene expression changes and predicts three transcriptional biomarkers in leukocytes.

本文引用的文献

1
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.新冠病毒木瓜样蛋白酶可拮抗ISG15依赖的传感器MDA5激活,以逃避宿主固有免疫。
Nat Microbiol. 2021 Apr;6(4):467-478. doi: 10.1038/s41564-021-00884-1. Epub 2021 Mar 16.
2
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
3
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)人类感染病例进行转录组学二次分析,确定了基因表达变化并预测了白细胞中的三种转录生物标志物。
Comput Struct Biotechnol J. 2023;21:1403-1413. doi: 10.1016/j.csbj.2023.02.003. Epub 2023 Feb 9.
4
The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation.单核细胞中的组蛋白甲基转移酶 MLL1/KMT2A 驱动冠状病毒相关的凝血障碍和炎症。
Blood. 2023 Feb 16;141(7):725-742. doi: 10.1182/blood.2022015917.
5
In vitro high-content tissue models to address precision medicine challenges.用于解决精准医学挑战的体外高通量组织模型。
Mol Aspects Med. 2023 Jun;91:101108. doi: 10.1016/j.mam.2022.101108. Epub 2022 Aug 17.
6
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.COVID-19 引发 ARDS 的机制:探索预防和治疗 SARS-CoV-2 的可能性。
Front Cell Infect Microbiol. 2022 Jun 14;12:931061. doi: 10.3389/fcimb.2022.931061. eCollection 2022.
7
Ultrastructural examination of lung "cryobiopsies" from a series of fatal COVID-19 cases hardly revealed infected cells.对一系列新冠肺炎死亡病例的肺部“低温活检”进行超微结构检查,几乎未发现受感染的细胞。
Virchows Arch. 2022 May;480(5):967-977. doi: 10.1007/s00428-022-03308-5. Epub 2022 Mar 16.
8
Putative Role of Vitamin D for COVID-19 Vaccination.维生素 D 对 COVID-19 疫苗接种的推测作用。
Int J Mol Sci. 2021 Aug 20;22(16):8988. doi: 10.3390/ijms22168988.
新型冠状病毒肺炎中受感染的巨噬细胞和 T 细胞之间的回路。
Nature. 2021 Feb;590(7847):635-641. doi: 10.1038/s41586-020-03148-w. Epub 2021 Jan 11.
4
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
5
Correlates of protection against SARS-CoV-2 in rhesus macaques.恒河猴中 SARS-CoV-2 保护作用的相关因素。
Nature. 2021 Feb;590(7847):630-634. doi: 10.1038/s41586-020-03041-6. Epub 2020 Dec 4.
6
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.SARS-CoV-2 通过半胱天冬酶-8 的激活引发炎症反应和细胞死亡。
Signal Transduct Target Ther. 2020 Oct 9;5(1):235. doi: 10.1038/s41392-020-00334-0.
7
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
8
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
9
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.与 COVID-19 相关的儿童炎症性多系统综合征的国家共识管理路径(PIMS-TS):全国德尔菲研究的结果。
Lancet Child Adolesc Health. 2021 Feb;5(2):133-141. doi: 10.1016/S2352-4642(20)30304-7. Epub 2020 Sep 18.
10
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.新冠病毒肺炎患者中中和抗体反应的快速产生
Cell Rep Med. 2020 Jun 23;1(3):100040. doi: 10.1016/j.xcrm.2020.100040. Epub 2020 Jun 8.